Issues related to Medicare Part B and Part D
2025 · 4th Quarter (Oct 1 - Dec 31)
BIOGEN INC.
Filed by JEFFREY J. KIMBELL & ASSOCIATES, INC..
Open official filingSource-reported fields
Filing overview
- Type
- 4th Quarter - Termination Amendment
- Posted
- Apr 20, 2026
- Income
- $50,000.00
- Expenses
- Not reported
- Registrant
- JEFFREY J. KIMBELL & ASSOCIATES, INC.
- Client
- BIOGEN INC.
- Filing UUID
- 9722a09b-1abb-41a8-83e9-8929cf39659f
- Termination date
- Dec 17, 2025
Literal source text
Lobbying issues and bill citations
Issues related to the pharmaceutical industry
Relationship and amount limits
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.